Abstract
An important strategy to circumvent the problem of antimicrobial resistance is to search for new compounds with antimicrobial activity. In this context, aminosterols, which include squalamine-like compounds and ceragenins, have gained interest due to their wide spectrum of antibacterial and antifungal properties. In light of recently reported data, we decided to analyze the mechanism of action of these compounds as well as their antimicrobial properties. Aminosterols are active against both bacterial reference strains and multidrug-resistant antibiotics as they disrupt the integrity of the bacterial membrane. Thus, these compounds could be useful in the development of new topical decontaminants or disinfecting agents.
Keywords: Squalamine, Aminosterol, Antimicrobial agents, Mechanism of action, antimicrobial resistance, ceragenins, aminosterol derivatives, multidrug-resistant, squalamine-like aminosterols (SLAs), sterol, synergistic com-bination, cholic acid, hyodeoxycholic acid, Pseudomonas aeruginosa, Haemophilus influenzae, Escherichia coli, Acinetobacter baumannii, Achromobacter xylosoxidans, Klebsiella pneumoniae, Burkholderia cepacia, Inquilinus limosus, Enterobacter aerogenes, Salmonella typhimurium, polyamino groups, cati-onic peptide antibiotics (CPAs), exopolysaccharides (EPSs), lipopolysaccharide (LPS), transmission electron microscopy (TEM), Plasmodium falciparum, aminosterols, Hemolytic Concentration (MHC), age-related macular degeneration (AMD), polymyxin analogs
Current Medicinal Chemistry
Title: Squalamine as an Example of a New Potent Antimicrobial Agents Class: A Critical Review
Volume: 17 Issue: 32
Author(s): K. Alhanout, J. M. Rolain and J. M. Brunel
Affiliation:
Keywords: Squalamine, Aminosterol, Antimicrobial agents, Mechanism of action, antimicrobial resistance, ceragenins, aminosterol derivatives, multidrug-resistant, squalamine-like aminosterols (SLAs), sterol, synergistic com-bination, cholic acid, hyodeoxycholic acid, Pseudomonas aeruginosa, Haemophilus influenzae, Escherichia coli, Acinetobacter baumannii, Achromobacter xylosoxidans, Klebsiella pneumoniae, Burkholderia cepacia, Inquilinus limosus, Enterobacter aerogenes, Salmonella typhimurium, polyamino groups, cati-onic peptide antibiotics (CPAs), exopolysaccharides (EPSs), lipopolysaccharide (LPS), transmission electron microscopy (TEM), Plasmodium falciparum, aminosterols, Hemolytic Concentration (MHC), age-related macular degeneration (AMD), polymyxin analogs
Abstract: An important strategy to circumvent the problem of antimicrobial resistance is to search for new compounds with antimicrobial activity. In this context, aminosterols, which include squalamine-like compounds and ceragenins, have gained interest due to their wide spectrum of antibacterial and antifungal properties. In light of recently reported data, we decided to analyze the mechanism of action of these compounds as well as their antimicrobial properties. Aminosterols are active against both bacterial reference strains and multidrug-resistant antibiotics as they disrupt the integrity of the bacterial membrane. Thus, these compounds could be useful in the development of new topical decontaminants or disinfecting agents.
Export Options
About this article
Cite this article as:
Alhanout K., M. Rolain J. and M. Brunel J., Squalamine as an Example of a New Potent Antimicrobial Agents Class: A Critical Review, Current Medicinal Chemistry 2010; 17 (32) . https://dx.doi.org/10.2174/092986710793205417
DOI https://dx.doi.org/10.2174/092986710793205417 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Epigenetic Regulators Governing Cancer Stem Cells and Epithelial- Mesenchymal Transition in Oral Squamous Cell Carcinoma
Current Stem Cell Research & Therapy Nanomedicines Based Drug Delivery Systems for Anti-Cancer Targeting and Treatment
Current Drug Delivery Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT
Current Cancer Drug Targets MET As a Potential Target for the Treatment of Upper Gastrointestinal Cancers: Characterization of Novel c-Met Inhibitors from Bench to Bedside
Current Medicinal Chemistry Emodin Enhances the Chemosensitivity of Endometrial Cancer by Inhibiting ROS-Mediated Cisplatin-resistance
Anti-Cancer Agents in Medicinal Chemistry Andrographolide Inhibits Osteopontin Expression and Breast Tumor Growth Through Down Regulation of PI3 Kinase/Akt Signaling Pathway
Current Molecular Medicine Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance
Current Pharmaceutical Design 4-Oxothiazolidines with Exocyclic C=C Double Bond(s): Synthesis, Structure, Reactions and Biological Activity
Current Organic Chemistry Angiogenesis: A Target for Cancer Therapy
Current Pharmaceutical Design Advances and Challenges in the Synthesis of Highly Oxidised Natural Phenols with Antiviral, Antioxidant and Cytotoxic Activities
Current Medicinal Chemistry Neurokinin-1 Receptor Antagonists in Lung Cancer Therapy
Letters in Drug Design & Discovery Effects of Tyrosine Kinase Inhibitors on Growth and Bone Metabolism in Children with Haematologic Malignancies
Cardiovascular & Hematological Agents in Medicinal Chemistry TLR7/9 Antagonists as Therapeutics for Immune-Mediated Inflammatory Disorders
Inflammation & Allergy - Drug Targets (Discontinued) Specific Immune Intervention with Monoclonal Antibodies for the Treatment of Multiple Sclerosis
Current Medicinal Chemistry Epigallocatechin-3-gallate(EGCG): Mechanisms and the Combined Applications
Combinatorial Chemistry & High Throughput Screening Restoring p53 Function in Cancer: Novel Therapeutic Approaches for Applying the Brakes to Tumorigenesis
Recent Patents on Anti-Cancer Drug Discovery Between Bench and Bed Side: PI3K Inhibitors
Current Molecular Pharmacology CFTR and MDR: ABC Transporters with Homologous Structure but Divergent Function
Current Genomics DNA Methylation Markers in Lung Cancer
Current Genomics The Protein Acetyltransferase ARD1: A Novel Cancer Drug Target?
Current Cancer Drug Targets